spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saunders, C. M.
Right arrow Articles by Lai, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, C. M.
Right arrow Articles by Lai, F. A.

PLC{zeta}: a sperm-specific trigger of Ca2+ oscillations in eggs and embryo development

Christopher M. Saunders1, Mark G. Larman2, John Parrington3, Llewellyn J. Cox1, Jillian Royse1, Lynda M. Blayney1, Karl Swann2 and F. Anthony Lai1,*

1 Cell Signalling Laboratory, Wales Heart Research Institute, University of Wales College of Medicine, Cardiff CF14 4XN, UK
2 Department of Anatomy and Developmental Biology, University College, London WC1E 6BT, UK
3 Department of Physiology, University College, London WC1E 6BT, UK



View larger version (30K):

[in a new window]
 
Fig. 1. Identification of a novel sperm PLC. (A) Immunoblot analysis of heparin-eluted soluble extracts of brain, kidney, liver and sperm (lanes B, K, L, S; 50 µg/lane) from mouse, boar and hamster, using antibody raised to the novel sperm PLC. Molecular weight markers in kDa, on the right. (B) Immunoblot of heparin-eluted soluble sperm proteins fractionated by gel filtration column chromatography on Sephacryl S-200 column. The underlined 150 kDa and 29 kDa indicate elution positions of gel filtration standards alcohol dehydrogenase and carbonic anhydrase, respectively. Shown below is the corresponding Ca2+ release activity of column fractions B, D and F assayed fluorometrically in sea urchin egg homogenates. Scale bars indicate time (seconds) and relative fluorescence units (RFU) (Jones et al., 1998bGo). Arrows indicate time of addition.

 


View larger version (57K):

[in a new window]
 
Fig. 2. Molecular cloning of mouse sperm PLC{zeta}. (A) Clustal alignment of mouse sperm PLC{zeta} with rat PLC{delta}1 (Accession number, P10688). Identical amino acids are shown in shaded black boxes, conservative substitutions in grey. (B) Schematic illustrating the predicted domain features of mouse PLC{zeta} and mammalian PLC isoforms ß, {gamma}, {delta}, and {epsilon}. (C) Sequence identity (blue) and similarity (red) between mammalian PLC isoforms (ß3, P51432; {gamma}2, AAH07565; {delta}1, P10688; {epsilon}, AAG17145; and {zeta}). (D) Dendrogram illustrating phylogeny of Clustal aligned mammalian PLC sequences. Tree branch lengths, indicating amino acid substitutions per residue, were 0.298 for {zeta}; 0.309-0.322 for {delta}1-4; 0.397 for {epsilon}; 0.400-0.413 for ß1-4; and 0.412-0.417 for {gamma}1-2.

 


View larger version (37K):

[in a new window]
 
Fig. 3. Sperm-specific expression of mouse PLC{zeta}. (A) Northern blot analysis of PLC{zeta} transcript distribution in mouse. Lanes from left to right: RNA standard markers, brain, heart, kidney, liver, lung, skeletal muscle, spleen, testis (2 µg polyA+-RNA/lane). Molecular weight markers in kb are on the left. (B) Immunoblot analysis of PLC{zeta} protein distribution in mouse. Left to right: brain, heart, kidney, liver, lung, skeletal muscle, sperm (50 µg protein/lane). Molecular weight markers in kDa are on the right. (C) Polymerase chain reaction detection of PLC{zeta} in cDNA from mouse spermatid and mouse testis devoid of spermatids. Left to right: DNA markers (2.0, 1.6, 1.0, 0.8, 0.6 and 0.5 kb, top to bottom), spermatid cDNA (10 ng), testis cDNA (10 ng), blank (no DNA) and positive control (1 ng PLC{zeta} plasmid).

 


View larger version (19K):

[in a new window]
 
Fig. 4. PLC{zeta} triggers Ca2+ oscillations in MII-arrested mouse eggs. (A) Dose-dependent Ca2+ oscillations in fura-red loaded mouse eggs triggered by microinjection of cRNA encoding mouse sperm PLC{zeta} (2 and 0.002 mg/ml, top and middle trace, respectively) and after preincubation with 10 µM cycloheximide (0.02 mg/ml, bottom trace). (B) Mean interspike interval of Ca2+ oscillations in eggs following microinjection of various PLC{zeta} cRNA concentrations (2-0.002 mg/ml in pipette, i.e. <0.1-0.0001 mg/ml in egg) compared with the interval observed upon in vitro fertilisation (IVF). Number of microinjected eggs is shown above each condition. *, significantly different from IVF at the 5% level (Student’s unpaired t-test).

 


View larger version (28K):

[in a new window]
 
Fig. 5. In vitro fertilisation consistent with PLC{zeta}-induced Ca2+ oscillations. Ca2+ changes in fura-red loaded mouse eggs that were either (A) in vitro fertilised with mouse sperm, or microinjected with cRNA encoding (B) PLC{zeta} at 0.02 mg/ml; (C) PLC{delta}1 at 2 mg/ml; (D) {Delta}PHPLC{delta}1 at 2 mg/ml (PH domain-deleted PLC{delta}1); (E) D210RPLC{zeta} at 2 mg/ml. (A-I,B-I) Expanded traces of the longer-duration, first Ca2+ transient taken from A,B, respectively. (F) Autoradiograph following SDS-PAGE of [35S]-labelled protein expressed in vitro from cRNA, lanes from left to right, of D210RPLC{zeta}, PLC{zeta}, {Delta}PHPLC {delta}1 and PLC{delta}1 corresponding to predicted protein sizes of 74, 74, 70 and 85 kDa, respectively.

 


View larger version (24K):

[in a new window]
 
Fig. 6. PLC{zeta} quantitation in cRNA-microinjected eggs and mouse sperm. (A) Ca2+ changes in a fura-red loaded mouse egg microinjected with cRNA encoding Myc-PLC{zeta} at 0.02 mg/ml. (B) Immunoblot analysis of Myc immunoreactive protein in uninjected (U) and Myc-PLC{zeta} cRNA-injected (I) mouse eggs (240 eggs/lane, 2 mg/ml, 5 hours post-injection). Molecular weight markers in kDa are on right. (C) Immunoblot and relative mobility analysis of native PLC{zeta} in mouse sperm (Sp, left panel, anti-PLC{zeta} antibody) and of Myc-PLC{zeta} in mouse eggs (right panel, anti-Myc antibody) microinjected with 1.0, 0.3 and 0.1 mg/ml Myc-PLC{zeta} cRNA (100 eggs/lane, 5 hours post-injection). 80 kDa protein marker is on the left. (D) Densitometric calibration plot of E. coli-purified Myc-PLC{zeta}-Histag protein using anti-PLC{zeta} antibody. Correlation coefficient, r=0.99. Broken line indicates interpolation of PLC{zeta} protein content corresponding to sperm extract derived from 4x105 mouse sperm.

 


View larger version (19K):

[in a new window]
 
Fig. 7. Ca2+ release activity in PLC{zeta}-immunodepleted soluble sperm extracts. (A) Immunoblot analysis of PLC{zeta} protein in hamster sperm extract supernatants after incubation with control IgG or anti-PLC{zeta} antibody (S- and S+, respectively) and the corresponding precipitated proteins bound to control IgG beads or anti-PLC{zeta} beads (P- and P+, respectively). (B) Ca2+ release activity of antibody-treated sperm supernatants, S– and S+, assayed fluorometrically in sea urchin egg homogenates. Scale bars indicate time (seconds) and relative fluorescence units (RFU). Arrows indicate time of addition (C) Ca2+ changes in fura-red loaded mouse eggs after microinjection with sperm extract that was either untreated (top trace), control IgG-treated (second trace, n=13) or anti-PLC{zeta} antibody-treated (bottom two traces, n=13). In 6/13 cases (third trace), the anti-PLC{zeta} antibody-treated sperm extract showed an injection artifact-related single Ca2+ spike; in other cases there was no Ca2+ change (fourth trace).

 


View larger version (39K):

[in a new window]
 
Fig. 8. Activation and embryo development to blastocyst in PLC{zeta}-injected mouse eggs. (A) Mouse eggs were either microinjected with PLC{zeta} cRNA (0.02 mg/ml), or parthenogenetically activated with strontium (5 mM, 4 hours) or fertilised with sperm in vivo, then placed in a 5% CO2 incubator at 37°C. Percentage of eggs reaching the two-cell stage after 24 hours, and morula/blastocyst stage after 96 hours, was recorded for each treatment. Number of microinjected eggs is shown above each condition. (B) Micrographs illustrating mouse embryos at the two-cell stage (left) and blastocyst stage (right), at 24 hours and 96 hours, respectively, after egg microinjection with PLC{zeta} cRNA (0.02 mg/ml). (C) Micrograph illustrating mouse egg 24 hours after microinjection with D210RPLC{zeta} cRNA (0.02 mg/ml).

 





© The Company of Biologists Ltd 2002